Boston Scientific | BSX - Ebitda

Aktienkurs
62.07
Täglich Wechseln
-3.62 -5.51%
Monatlich
-11.05%
Jährlich
-39.09%
Q2 Prognose
60.74




Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
AtriCure USD 19.86M 2.06M 2025-12
Avanos Medical USD 10M 73.9M 2025-09
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
CONMED USD 80.36M 49.87M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Danaher USD 1.92B 204M 2026-03
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Illumina USD 332M 12M 2025-09
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Zimmer Biomet Holdings USD 759M 120.8M 2025-12